Prostate cancer Board decisions

The Veteran's prostate cancer is presumed to be related to his in-service exposure to herbicide agents, specifically those used along the Korean DMZ. The Board granted service connection for this condition.

The Veteran's disability rating for prostate cancer residuals was reduced from 100% to 60%, effective March 1, 2010. The reduction was proper as the evidence showed no recurrence of prostate cancer and the Veteran was not undergoing treatment.,SMC based on housebound status was restored effective March 1, 2010, due to the Veteran's service-connected bowel incontinence precluding him from maintaining gainful employment.

The Board has remanded the case for further development, including obtaining VA treatment records and scheduling a VA examination of the Veteran's thoracic spine disability. The claim will be readjudicated after these actions.

The Veteran's service-connected disabilities render him unable to obtain and maintain substantially gainful employment, and the Board has granted TDIU as of the date of claim.

The Veteran's pelvic scar is rated as 10 percent disabling due to pain and noncompensable otherwise. The prostate cancer residuals are currently rated at 40 percent, which is the maximum rating available under DC 7528.,Erectile dysfunction resulting from prostatectomy surgery is not compensable.

The Board found that the Veteran's prostate cancer is not related to his military service and denied the claim. The issue of a higher initial rating for colon cancer residuals remains pending.

The Board has remanded this case for further development, including verifying service dates and exposure to hazardous chemicals. The Veteran's prostate cancer and leukemia claims are reopened due to new evidence, but the exact nature of the connection remains unclear.

The Board has determined that the Veteran's diabetes, prostate cancer, and hypertension are not related to his active service. The claims for increased ratings of left knee disabilities and entitlement to a TDIU have been remanded.

The Board found no evidence of exposure to Agent Orange or asbestos during service, and thus denied the Veteran's claims for service connection. The prostate cancer was not shown to be related to service or a service-connected disability, and erectile dysfunction is also not linked to service.

The Veteran's cause of death was cardiac arrest due to dementia, with prostate cancer and seizure disorder contributing. The VA has determined that there is no service connection for any of these conditions.

The Board has denied the Veteran's claims for service connection for diabetes mellitus, Parkinson's disease, erectile dysfunction, and prostate cancer. The issues of whether new and material evidence has been received to reopen previously denied claims for sleep apnea and coronary artery disease are also pending.

The Veteran's service connection claims for coronary artery disease, diabetes mellitus, and prostate cancer are granted as they are presumed to be related to herbicide agent exposure during his service in the Republic of Vietnam.

The Board found that the reduction in the rating for prostate cancer residuals from 100% to 40% was proper, and denied entitlement to a higher rating. The Veteran also met the criteria for TDIU due to his service-connected disabilities.

The Veteran's service-connected disabilities do not preclude him from securing or following substantially gainful employment consistent with his education and employment background.

The Board has remanded the case for further development regarding the Veteran's exposure to radiation during service and its impact on his claimed conditions. The claim will be reviewed after obtaining additional records and a dose estimate if necessary.

The Veteran's prostate cancer is found to be due to in-service herbicide exposure and service connection is granted.

The Veteran's claims for service connection are being remanded due to the need for further development regarding his exposure to carbon tetrachloride and ionizing radiation during service.

The Board denied the Veteran's claim for service connection for prostate cancer as due to Agent Orange exposure, finding no evidence of in-service exposure or a link between his current condition and his military service.

The Veteran's claims for increased ratings for PTSD and voiding dysfunction as a residual of prostate cancer were denied due to his failure to report for necessary VA examinations.

The Veteran's prostate cancer residuals were rated at 60 percent from November 1, 2013 to February 6, 2015. The rating was granted based on the criteria for voiding dysfunction due to prostate cancer treatment.